Topics

Companies Related to "eighth edition Topics Anti Cancer Research been issued" [Most Relevant Company Matches] RSS

08:18 EST 21st February 2020 | BioPortfolio

Here are the most relevant search results for "eighth edition Topics Anti Cancer Research been issued" found in our extensive corporate database of over 50,000 company records.

Showing "eighth edition Topics Anti Cancer Research been issued" Companies 1–25 of 8,900+

Relevant

Synergys Biotherapeutics

Synergys is an early stage company developing multifunctional anti-vascularization antibody drugs targeting VEGF-alternative pathways. The Company’s most advanced product candidate, Anti-EGFR‐TAP (SYN001) was derived from its platform technology termed A‐TAP (Antibody-Targeted Anti-Vascularization Payload). SYN001 is currently in preclinical ...


Gibson Oncology, LLC

Gibson is a private oncology drug development company dedicated to bringing its novel, cost-effective, and very well-tolerated Indeno anti-cancer treatments to market. Gibson intends to develop these novel anti-cancer drugs in advanced-stage cancer patients as single agent and in combination treatments with both immunotherapy and targeted therapies.

Nu Skin Enterprises, Inc.

Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its comprehensive anti-aging product portfolio, independent business opportunity and corporate social responsibility initiatives. Nu Skin's scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company, evidenced in its unique ageLOC(TM) science that addresses aging at its sou...


Biothera Pharmaceuticals Inc.

Biothera Pharmaceuticals is a privately held biotechnology company developing Imprime PGG, a first-in-class, mid-clinical stage cancer immunotherapy that orchestrates an integrated anti-cancer immune response in combination with checkpoint inhibitors and tumor-targeting and anti-angiogenesis monoclonal antibodies. Imprime PGG has been well-tolerated in tri...

StudyManager, Inc

Seattle-based StudyManager is a leading provider of clinical trial software to the biopharmaceutical and clinical research industries. Since 1993, StudyManager has been helping make clinical trial management faster, easier, and more efficient. Their flagship product, Investigator Edition, is an end-to-end solution for research sites, universities, and hospitals that streamlines clinical research, ...

Lpath

Lpath, Inc., headquartered in San Diego, California, is a theranostics company focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases. Lpath's lead product candidate, Sphingomab™, is a monoclonal antibody (mAb) against a validated cancer target, sphingosine-1-phosphate (S1P), and has demonstrated compelling results against six different forms of sol...

Sopherion Therapeutics, LLC

Sopherion Therapeutics, LLC is a privately-held biotechnology company based in Princeton, New Jersey. The Company is focused on developing novel anti-cancer therapies for patients suffering from advanced cancer, particularly in the metastatic stage. Sopherion is dedicated to the acquisition, discovery, development and commercialization of novel anti-cancer therapies with unique therapeutic activi...

Emmerex

Emmerex is an early stage bio-pharmaceutical company. It aims to bring to market an anti-cancer therapy. The Emmerex therapy arose as a result of several years' biological research. It has already been proven to be safe in patients. The Emmerex therapy utilises the patients' own innate ability to fight cancer. It cuts off nutrient source of the cancer and attacks the tumours directly. The Emmerex ...

Gateway for Cancer Research

Gateway for Cancer Research℠ is a nonprofit 501(c)(3) organization committed to funding innovative cancer research that helps people living with cancer. 99 cents of every dollar Gateway receives directly funds cancer clinical trials at leading research institutions. Get involved today by visiting www.GatewayCR.org.

Drug Topics

Twice-monthly news magazine reports on all phases of pharmacy for community & health-system pharmacists, HMO & consultant pharmacists, chain headquarters executives & buyers, mail-order pharmacists, wholesalers, academia, & others. Concise, easy-to-read news reports cover managed care trends; professional issues; national & state governmental activities; new prescription drugs, OTCs, and health & ...

Cancer Research Ventures

Cancer Research Ventures Ltd (CRV) and its forerunner Cancer Research Campaign Technology Limited (CRCT) have been providing technology transfer services to cancer researchers since 1987 with the aim of developing much needed new treatments from cancer research.

European Organisation for Research and Treatment of Cancer (EORTC)

The aims of the European Organisation for Research and Treatment of Cancer (EORTC) are to develop, conduct, coordinate, and stimulate laboratory and clinical research in Europe to improve the management of cancer and related problems by increasing survival but also patients’ quality of life. Extensive and comprehensive research in this wide field is often beyond the means of individualEuropean l...

Corporate Communications, CEL-SCI Corporation

CEL-SCI Corporation (AMEX: CVM), a biotechnology company, was formed in 1983. CEL-SCI is involved in the research and development of drugs and vaccines for the treatment of cancer and infectious diseases. The Company’s core capabilities include drug discovery, research, development and manufacturing of complex biological substances.Recurrence of cancer is the greatest fear for the cancer patient...

Cancer Research UK

Cancer Research UK is the world's leading independent organisation dedicated to cancer research.With an annual scientific spend of £217 million, we fund over 3,000 world-class scientists, doctors and nurses in England, Scotland, Wales and Northern Ireland. Their combined expertise puts us at the forefront of cancer research. Indeed, we were recently ranked among the top three biomedical research ...

Goodwin Institute for Cancer Research

The Rumbaugh-Goodwin Institute for Cancer Research, Inc. (RGI) is a nonprofit cancer research facility dedicated to investigating and studying numerous types of cancer. Our goal is to find a cure or control for each cancer.

Panagin Pharmaceuticals Inc.

Panagin Pharmaceuticals Inc., a privately-held biotech company, specializes in the discovery, research, development and commercialization of saponin based anti-cancer drugs. Panagin's proprietary new drug candidates show strong anti-cancer properties against various advanced, metastatic, multi-drug resistant cancers. Panagin's research and clinical programs focus on life-threatening diseases, such...

Mayne Pharma (USA) Inc

Mayne Pharma is an international leader in injectably generic and specialty pharmaceuticals and cost effective products. We focus on the research, development, manufacture, marketing and distribution of generic and specialty pharmaceutical products primary sold in the hospital setting. Our portfolio has been built around expertise in injectable generic oncology (anti-cancer) medicines and has now ...

Epitomics, Inc.

Epitomics, Inc., an emerging biotechnology company, is dedicated to developing breakthrough monoclonal antibody technology for research, diagnostic and therapeutic applications. The company utilizes a unique and proprietary RabMAb® (Rabbit Monoclonal Antibody) technology which produces antibodies with superior binding affinity and bioactivity in a wide variety of biological assays. Epitomics, Inc...

Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world’s largest philanthropic source of support for accelerating the world’s most promising research for discovering better treatments and cures for prostate cancer. Founded in 1993, the PCF has raised nearly $400 million and provided funding to more than 1,500 researchers at nearly 200 institutions wor...

National Foundation for Cancer Research

The National Foundation for Cancer Research (NFCR) is a leading charity dedicated to funding cancer research and public education relating to cancer prevention, earlier diagnosis, better treatments and, ultimately, cures for cancer. NFCR promotes and facilitates collaboration among scientists to accelerate the pace of discovery from bench to bedside.

AMC Cancer Research Center |

AMC Cancer Research Foundation at the University of Colorado Cancer Center (UCCC), where we pursue new and better ways to prevent and treat cancer. As the only cancer center in the Rocky Mountain region to receive designation as a comprehensive cancer center by the National Cancer Institute, UCCC has some of the nation's most respected researchers and physicians working together to end suffering f...

Geron Corporation

Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The company is advancing an anti-cancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials in different cancers. For more information, visit ...

The Prostate Cancer Foundation

The Prostate Cancer Foundation is the world’s largest philanthropic source of support for prostate cancer research focused on discovering better treatments and a cure for prostate cancer at every stage of diagnosis. Founded in 1993, the PCF has raised more than $370 million and provided funding to more than 1,500 research projects at nearly 200 instit...

Dorland

The first dictionary in the Dorland's line, the American Pocket Medical Dictionary, edited by W.A. Newman Dorland, AM, MD, was first published in 1898 and was a small volume just over 500 pages long. It was followed two years later by the American Illustrated Medical Dictionary. Both sprang from the fertile mind of Ryland W. Green, the illustrious longtime editor-in-chief at the W.B. Saunders Comp...

Global News Group, Inc.

The Global News Group and Special Edition TV is a team of EMMY, Telly and Peabody award winning journalists, producers and directors. Special Edition TV covers the latest in business and technology from innovators and industry leaders. Select companies are provided with international exposure via customized news reports reaching industry leaders and people...


More From BioPortfolio on "eighth edition Topics Anti Cancer Research been issued"

Quick Search

Corporate Database Quicklinks